Faeth Therapeutics (FTH) Current Leases (2020 - 2026)
Faeth Therapeutics' (FTH) quarterly Current Leases came in at $18000.0 in Q1 2026, down 98.85% YoY from $1.6 million in Q1 2025, and down 98.69% on a QoQ basis from $1.4 million in Q4 2025.
Faeth Therapeutics (FTH) Current Leases (2020 - 2026) Analysis & Trends
Faeth Therapeutics (FTH) has 7 years of Current Leases data on file, last reported at $18000.0 in Q1 2026.
- Quarterly Current Leases fell 98.85% year-over-year to $18000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18000.0 (down 98.85% YoY) and the FY2025 annual result came in at $1.4 million, up 87.16% from the prior year.
- Current Leases retreated to $18000.0 in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.6 million in Q2 2025 to a low of $18000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $1.2 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2025 — Current Leases soared 87.73% — and 2026, when it plunged 98.85%.
- Tracing FTH's Current Leases over 5 years: stood at $880000.0 in 2022, then surged by 78.07% to $1.6 million in 2023, then plunged by 53.29% to $732000.0 in 2024, then jumped by 87.16% to $1.4 million in 2025, then tumbled by 98.69% to $18000.0 in 2026.
- The last three Current Leases figures came in at $18000.0 (Q1 2026), $1.4 million (Q4 2025), and $193000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Faeth Therapeutics | 180.89 Mn | 180.89 Mn | - | 592,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 592,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 193,000.00 |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 1.57 Mn |
| Dec 31, 2024 | 732,000.00 |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 864,000.00 |
| Mar 31, 2024 | 871,000.00 |
| Dec 31, 2023 | 1.57 Mn |
| Sep 30, 2023 | 874,000.00 |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 880,000.00 |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 798,000.00 |
| Mar 31, 2022 | 1.16 Mn |
| Dec 31, 2021 | 680,000.00 |
| Dec 31, 2020 | 32,000.00 |